Trial Profile
Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2011
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 07 Apr 2011 New trial record